OMRON Corporation (OMRNF)
OTHER OTC:OMRNF
Want to see OMRNF full AI Analyst Report?
OMRNF Stock Chart & Stats
$26.50
$0.00(0.00%)
At close: 4:00 PM EST
$26.50
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$22.87 - $42.25
Previous CloseN/A
Volume23.00
Average Volume (3M)0.00
Market Cap
$7.85B
Enterprise Value$1.30T
Total Cash (Recent Filing)$155.20B
Total Debt (Recent Filing)$228.95B
Price to Earnings (P/E)36.8
Beta0.56
Next Earnings
May 13, 2026EPS Estimate
0.72Next Dividend Ex-DateN/A
Dividend Yield2.39%
Share Statistics
EPS (TTM)119.04
Shares Outstanding206,244,870
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)1.07
Price to Sales (P/S)1.03
P/FCF Ratio122.12
Enterprise Value/Market Cap165.90
Enterprise Value/Revenue1.56
Enterprise Value/Gross Profit3.57
Enterprise Value/Ebitda15.23
Forecast
1Y Price Target
$41.37Price Target Upside56.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.5
Revenue Forecast (FY)$5.71B
Bulls Say, Bears Say
Bulls Say
Diversified Product PortfolioOMRON's mix of factory automation, sensors, motion/robotics, software/services and healthcare devices spreads revenue across industrial and consumer healthcare end markets. This diversification supports steadier demand, cross‑sell opportunities and resilience to single‑industry cyclicality over months to years.
Revenue MomentumSustained TTM revenue growth indicates recovering end‑market demand and product uptake. Continued top‑line momentum improves the opportunity for operating leverage and margin recovery, financing incremental R&D and capex without relying solely on balance sheet moves in the medium term.
Solid Capital Base And Moderate LeverageA large equity base and only moderate net leverage provide financial flexibility to support capex, R&D and working capital needs. This capital strength underpins strategic optionality (product investment, targeted M&A) and helps absorb cyclical swings over a 2‑6 month to multi‑year horizon.
Bears Say
Weak Cash ConversionVery low free cash flow and poor cash conversion constrain the firm's ability to self‑fund investments, dividends or buybacks. Volatile, thin FCF increases reliance on external financing and reduces margin for error versus peers, limiting durable financial flexibility.
Subdued ProfitabilityPersistently low operating and net margins reduce the company's ability to accumulate retained earnings and generate high returns. Even with revenue growth, thin margins make earnings and ROE sensitive to cost inflation and competitive pricing pressure, challenging sustainable profit recovery.
Rising Leverage And Low ROEAn increase in financial leverage versus prior years, combined with ROE near 3%, signals weaker capital efficiency and reduced financial conservatism. Higher indebtedness magnifies interest and refinancing risk and can limit strategic investments if profitability does not improve sustainably.
OMRON News
OMRNF FAQ
What was OMRON Corporation’s price range in the past 12 months?
OMRON Corporation lowest stock price was $22.87 and its highest was $42.25 in the past 12 months.
What is OMRON Corporation’s market cap?
OMRON Corporation’s market cap is $7.85B.
When is OMRON Corporation’s upcoming earnings report date?
OMRON Corporation’s upcoming earnings report date is May 13, 2026 which is in 3 days.
How were OMRON Corporation’s earnings last quarter?
OMRON Corporation released its earnings results on Feb 05, 2026. The company reported $0.169 earnings per share for the quarter, missing the consensus estimate of $0.356 by -$0.187.
Is OMRON Corporation overvalued?
According to Wall Street analysts OMRON Corporation’s price is currently Undervalued.
Does OMRON Corporation pay dividends?
OMRON Corporation pays a Semiannually dividend of $0.331 which represents an annual dividend yield of 2.39%. See more information on OMRON Corporation dividends here
What is OMRON Corporation’s EPS estimate?
OMRON Corporation’s EPS estimate is 0.72.
How many shares outstanding does OMRON Corporation have?
OMRON Corporation has 206,244,870 shares outstanding.
What happened to OMRON Corporation’s price movement after its last earnings report?
OMRON Corporation reported an EPS of $0.169 in its last earnings report, missing expectations of $0.356. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of OMRON Corporation?
Currently, no hedge funds are holding shares in OMRNF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OMRON Corporation
OMRON Corporation engages in industrial automation, electronic and mechanical components, social systems, and healthcare businesses worldwide. The company's Industrial Automation Business offers sensors, switches, safety and control components, relays, automation systems, motion/drives, robotics, energy conservation support/environment measure equipment, and power supplies. Its Electronic and Mechanical Components Business provides relays, switches, connectors, sensors, and components/units for amusement equipment. The company's Social Systems, Solutions and Service Business offers terminals and systems, including PV inverters and storage batteries; railway station systems, such as automated ticket gates and ticket vending machines, traffic and road management systems, payment systems, and UPS that protect equipment from unexpected power disruption; a range of solutions comprising software development and maintenance services to support the social infrastructure; and transport management systems and infrastructure monitoring systems. Its Healthcare Business offers blood pressure monitors; nebulizers; electrotherapy TENS devices; digital thermometers; body composition monitors; and other products, such as activity monitors, AEDs, etc. OMRON Corporation has an agreement with JMDC Inc. to jointly develop personalized aggravation and nursing care prevention solutions that support prescription medication treatments and patient lifestyle changes by predicting the risk of the onset of individual patient events. The company was formerly known as OMRON Tateisi Electronics Co. and changed its name to OMRON Corporation in January 1990. OMRON Corporation was founded in 1933 and is headquartered in Kyoto, Japan.
OMRNF Company Deck
OMRNF Earnings Call
Q3 2026
0:00 / 0:00
OMRNF Stock 12 Month Forecast
Average Price Target
$41.37
▲(56.12% Upside)
Technical Analysis
Alps Alpine Co
―
Keyence
―
MinebeaMitsumi
―
Murata Manufacturing Co
―
TDK Corporation
―
Ownership Overview
―
Insiders
4.78% Mutual Funds
― Other Institutional Investors
87.92% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---